General - Laatste dingen 1 Flashcards

1
Q

ERU
a. GYS-1
b. TRPM1
c. RYR1
d. GBE1

A

b. TRPM1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

timolol
a. B adrenerge receptor blocker
B. koolzuuranhydrase remmer

A

a. B adrenerge receptor blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

dorzolamide
a. B adrenerge receptor blocker
B. koolzuuranhydrase remmer

A

B. koolzuuranhydrase remmer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Leptin in obese donkeys
a. higher
b. lower

A

a. higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type A lactic acidosis
a. hypoxia
b. abscence of hypoxemia

A

a. hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Leptin in old donkeys
a. higher
b. lower

A

a. higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type B lactic acidosis
a. hypoxia
b. abscence of hypoxemia

A

b. abscence of hypoxemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dobutamine
a. B1 agonist
b. B2 agonist
c. a1 agonist
d. a2 agonist

A

a. B1 agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Norepinephrine
a. B1 agonist
b. B2 agonist
c. a1 agonist
d. a2 agonist

A

c. a1 agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Epineephrine
a. a
b. b
c. a en b

A

c. a en b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Phenylefrine
a. a
b. b
c. a en b

A

a. a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lower PCO2
a. left shift
b. right shift

A

a. left shift

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lower [H+]
a. left shift
b. right shift

A

a. left shift

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Higher temp
a. left shift
b. right shift

A

b. right shift

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Higher DPG
a. left shift
b. right shift

A

b. right shift

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lower [PO4,3-]
a. left shift
b. right shift

A

a. left shift

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lower pH
a. left shift
b. right shift

A

b. right shift

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Higher pH
a. left shift
b. right shift

A

a. left shift

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hydrophobic / low surface tension
a. SP-B and SP-C
b. SP-A and SP-D

A

a. SP-B and SP-C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hydrophilic / antimicrobial
a. SP-B and SP-C
b. SP-A and SP-D

A

b. SP-A and SP-D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Medial compartment
a. IX, XI, XII
b. V, VII, VIII

A

a. IX, XI, XII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lateral compartment
a. IX, XI, XII
b. V, VII, VIII

A

b. V, VII, VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

African horse sickness
a. Culicoides imicola (biting midge)

A

a. Culicoides imicola (biting midge)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

EIV
a. RNA
b. DNA

A

a. RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

EHV
a. RNA
b. DNA

A

b. DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MH
a. RYR1
b. GYS-1
c. TRPM1
d. GBE1

A

a. RYR1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

PSSM
a. RYR1
b. GYS-1
c. TRPM1
d. GBE1

A

b. GYS-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

GBED
a. RYR1
b. GYS-1
c. TRPM1
d. GBE1

A

d. GBE1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

HYPP
a. RYR1
b. SCN4A
c. GYS-1
d. TRPM1

A

b. SCN4A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Excitatory neurotransmitters
a. glutamate, aspartate and acetylcholine
b. GABA, glycine, taurine, norepinephrine

A

a. glutamate, aspartate and acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Inhibitory neurotransmitters
a. glutamate, aspartate and acetylcholine
b. GABA, glycine, taurine, norepinephrine

A

b. GABA, glycine, taurine, norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Type 1 diabetes mellitus
a. non-insulin dependent (tissue sensitivity impaired)
b. insulin dependent (lack of insulin)

A

b. insulin dependent (lack of insulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Type 2 diabetes mellitus
a. non-insulin dependent (tissue sensitivity impaired)
b. insulin dependent (lack of insulin)

A

a. non-insulin dependent (tissue sensitivity impaired)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Congential agangliosis
a. RYR1
b. SCN4A
c. EDNRB
d. TRPM1

31
Q

Zone 1
a. periportal
b. centrolubular

A

a. periportal

32
Q

Zone 3
a. periportal
b. centrolubular

A

b. centrolubular > KLOPT DIT?

33
Q

Highest p450 mixed function oxidase
a. Zone 1
b. Zone 2
c. Zone 3

34
Q

Highest p450 mixed function oxidase
a. periportal
b. centrolubular

A

b. centrolubular > KLOPT DIT?

35
Q

Insulin vs. lipoprotein lipase
a. stimulation
b. inhibition

A

a. stimulation

36
Q

Glucocorticoids vs. lipoprotein lipase
a. stimulation
b. inhibition

A

b. inhibition

37
Q

Growth hormone vs. lipoprotein lipase
a. stimulation
b. inhibition

A

b. inhibition

38
Q

Azotemia vs. lipoprotein lipase
a. stimulation
b. inhibition

A

b. inhibition

39
Q

Insulin vs. hormone sensitive lipase
a. stimulation
b. inhibition

A

b. inhibition

40
Q

Glucocorticoids vs. hormone sensitive lipase
a. stimulation
b. inhibition

A

a. stimulation

41
Q

Growth hormone vs. hormone sensitive lipase
a. stimulation
b. inhibition

A

a. stimulation

42
Q

Azotemia vs. hormone sensitive lipase
a. stimulation
b. inhibition

A

a. stimulationI

43
Q

Insulin vs. gluconeogenesis
a. stimulation
b. inhibition

A

b. inhibition

44
Q

Glucocorticoids vs. gluconeogenesis
a. stimulation
b. inhibition

A

a. stimulation

45
Q

Glucagon vs. gluconeogenesis
a. stimulation
b. inhibition

A

a. stimulation

46
Q

Catecholamines vs. gluconeogenesis
a. stimulation
b. inhibition

A

a. stimulation

47
Q

Insulin vs. glycogenolysis
a. stimulation
b. inhibition

A

b. inhibition

48
Q

Glucocorticoids vs. glycogenolysis
a. stimulation
b. inhibition

A

a. stimulation

49
Q

Glucagon vs. glycogenolysis
a. stimulation
b. inhibition

A

a. stimulation

50
Q

Insulin vs. fatty acid synthesis in liver
a. stimulation
b. inhibition

A

a. stimulation

51
Q

Phase 1
a. oxygenation
b. conjugation

A

a. oxygenation

52
Q

Phase 1
a. hydroxylation
b. conjugation

A

a. hydroxylation

53
Q

Phase 1
a. deamination
b. conjugation

A

a. deamination

54
Q

Phase 1
a. reduction
b. conjugation

A

a. reduction

55
Q

Phase 2
a. hydroxylation
b. conjugation
c. deamination
d. reduction

A

b. conjugation

55
Q

Centrilobular zonal injury
a. zone 1
b. zone 2
c. zone 3

56
Q

Periacinar (paracentral)
a. zone 1
b. zone 2
c. zone 3

56
Q

Compensatory pause
a. APCs
b. VPCs

57
Q

Acinuar lobular injury
a. zone 1
b. zone 2
c. zone 3

57
Q

Periportal injury
a. zone 1
b. zone 2
c. zone 3

58
Q

Conjugated <25%
a. hepatocellular disease
b. cholestasis

A

a. hepatocellular disease

58
Q

Vitamine K dependent factors
a. III, IV, VIII, protein C
b. II, IV, XI, XII, protein C
c. IV, VI, IX, XI, protein C
d. II, VII, IX, X protein C

A

d. II, VII, IX, X and protein C

58
Q

Volume overload receiving chamber VSD
a. LA and LV
b. RA and RV

A

a. LA and LV

58
Q

Conjugated >30%
a. hepatocellular disease
b. cholestasis

A

b. cholestasis

58
Q

Which valve has 2 cups?
a. tricuspid
b. mitral
c. pulomary
d. aorta

58
Q

Volume overload receiving chamber PDA
a. LA and LV
b. RA and RV

A

a. LA and LV

58
Q

Eccentric hypertrophy
a. endurance-trained
b. resistance trainend

A

a. endurance-trained

58
Q

Concentric hypertrophy
a. endurance-trained
b. resistance trainend

A

b. resistance trainend

58
Q

Volume overload receiving chamber ASD
a. LA and LV
b. RA and RV

A

b. RA and RV

58
Q

S1
a. atrioventricular valve closure
b. semilunar valve closure
c. rapid ventricular filling
d. atrial contraction

A

a. atrioventricular valve closure

58
Q

S2
a. rapid ventricular filling
b. atrial contraction
c. semilunar valve closure
d. atrioventricular valve closure

A

b. semilunar valve closure

58
Q

S4
a. atrioventricular valve closure
b. semilunar valve closure
c. rapid ventricular filling
d. atrial contraction

A

d. atrial contraction

58
Q

S3
a. rapid ventricular filling
b. semilunar valve closure
c. atrioventricular valve closure
d. atrial contraction

A

a. rapid ventricular filling

59
Q

Non-compensatory pause
a. APCs
b. VPCs

60
Q

PT
a. V, VIII, IX, X, XI, XII, prothrombin, fibrinogen
b. V, VII, X, prothrombin, fibrinogen

A

b. V, VII, X, prothrombin, fibrinogen

61
Q

aPTT
a. V, VIII, IX, X, XI, XII, prothrombin, fibrinogen
b. V, VII, X, prothrombin, fibrinogen

A

a. V, VIII, IX, X, XI, XII, prothrombin, fibrinogen

62
Q

A1 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues

A

a. no cutaenous involvement

63
Q

A2 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues

A

b. no cutaenous involvement but locally invasive

64
Q

B1 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues

A

c. overlying skin cannot be moved over nodule, no deep tissue invasion

65
Q

B2 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues

A

d. overlying skin cannot be moved over nodule, attached to deeper tissues